Document is current
Any future updates will be listed below
-
Authors
Cappellesso, Federica
Orban, Marie-Pauline
Shirgaonkar, Niranjan https://orcid.org/0000-0001-6078-1409
Berardi, Emanuele https://orcid.org/0000-0002-0775-9605
Serneels, Jens
Neveu, Marie-Aline
Di Molfetta, Daria
Piccapane, Francesca
Caroppo, Rosa
Debellis, Lucantonio
Ostyn, Tessa
Joudiou, Nicolas https://orcid.org/0000-0002-6760-7400
Mignion, Lionel https://orcid.org/0000-0002-9426-8600
Richiardone, Elena
Jordan, Bénédicte F.
Gallez, Bernard
Corbet, Cyril https://orcid.org/0000-0001-8795-9131
Roskams, Tania
DasGupta, Ramanuj https://orcid.org/0000-0001-9015-3729
Tejpar, Sabine
Di Matteo, Mario
Taverna, Daniela
Reshkin, Stephan J. https://orcid.org/0000-0001-9757-5908
Topal, Baki https://orcid.org/0000-0002-2687-7535
Virga, Federico
Mazzone, Massimiliano https://orcid.org/0000-0001-8824-4015
- License Information
-
More Information
Article History
Received: 5 November 2021
Accepted: 21 October 2022
First Online: 15 December 2022
Competing interests
: A patent application entitled ‘Inhibition of SLC4A4 in the treatment of cancer’, listing M.M., F.C. and F.V. as inventors, has been filed on 17 February 2021 (EP 21157705.1) and was published as WO 2022/175392. All the other authors declare no competing interests.
